Osteoporosis prevention: where are the barriers to improvement in a French general population? A qualitative study.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 18 01 2018
accepted: 24 09 2018
pubmed: 12 10 2018
medline: 7 5 2019
entrez: 12 10 2018
Statut: ppublish

Résumé

We conducted a qualitative study with French men and women in order to provide insight into individuals' experiences, behaviors, and perceptions about osteoporosis (OP) and OP care. The data showed that both sexes, but especially men, were unfamiliar with OP, did not always feel concerned, and mistrusted pharmacological treatments. To engage actively in osteoporosis (OP) prevention, people need to have basic knowledge about the disease. The aim of this qualitative study was to explore knowledge and representations of OP care and prevention among both men and women. Focus groups were conducted in the Rhône-Alpes Region, France, with women aged 50-85 years and men aged 60-85 years, with or without a history of fragility fracture and/or an OP diagnosis (respectively referred to as "aware" or "unaware"). A total of 45 women (23 "aware" and 22 "unaware" in 5 and 4 focus groups, respectively) and 53 men (19 "aware" and 34 "unaware" in 3 and 4 focus groups, respectively) were included. A thematic analysis of transcripts was performed to explore knowledge and representations about OP, risk factors, prevention, and treatment. The data showed that both sexes, but especially men, had limited knowledge of OP and considered it as a natural aging process not related to fragility fractures. They generally did not feel concerned by OP and no important difference was observed between "aware" and "unaware" patients. Women expressed their fear of the disease, associated with aging and the end of life, while men considered it to be a women's disease only. Both sexes were aware of OP risk factors, but were suspicious towards treatments because of the associated side effects. Understanding people's representation of OP might help to provide patients with relevant information in order to optimize their preventive behavior and decrease the burden of the disease.

Identifiants

pubmed: 30306220
doi: 10.1007/s00198-018-4720-5
pii: 10.1007/s00198-018-4720-5
doi:

Substances chimiques

Bone Density Conservation Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

177-185

Références

Osteoporos Int. 2017 May;28(5):1549-1558
pubmed: 28246884
Osteoporos Int. 2011 Mar;22(3):797-801
pubmed: 20517692
Joint Bone Spine. 2012 May;79(3):304-13
pubmed: 22521109
J Bone Miner Res. 2010 Nov;25(11):2313-23
pubmed: 20499368
BMC Musculoskelet Disord. 2008 Mar 21;9:38
pubmed: 18366716
Can Fam Physician. 2008 Aug;54(8):1140-1141, 1141.e1-5
pubmed: 18697977
Osteoporos Int. 2013 Feb;24(2):393-406
pubmed: 22829395
Joint Bone Spine. 2005 Dec;72(6):562-6
pubmed: 15996502
Maturitas. 2011 Jan;68(1):5-12
pubmed: 20950969
J Mens Health. 2011 Oct;8(3):185-191
pubmed: 22125585
Can Fam Physician. 2008 Mar;54(3):394-402
pubmed: 18337534
BMJ. 1995 Jul 29;311(7000):299-302
pubmed: 7633241
Scand J Prim Health Care. 2007 Sep;25(3):160-5
pubmed: 17846934
Arch Osteoporos. 2016 Dec;11(1):33
pubmed: 27739032
J Eval Clin Pract. 2010 Jun;16(3):590-6
pubmed: 20102434
Osteoporos Int. 2013 Jan;24(1):23-57
pubmed: 23079689
Arch Osteoporos. 2013;8:137
pubmed: 24113838
Maturitas. 2006 May 20;54(2):127-34
pubmed: 16257152
PLoS One. 2016 Aug 05;11(8):e0160661
pubmed: 27494284
Drug Des Devel Ther. 2013 Aug 22;7:849-60
pubmed: 24009413
Osteoporos Int. 2012 May;23(5):1623-9
pubmed: 21476038
Osteoporos Int. 2012 Dec;23(12):2829-34
pubmed: 22310958
Curr Osteoporos Rep. 2013 Mar;11(1):52-60
pubmed: 23334619
J Bone Miner Res. 1994 Aug;9(8):1137-41
pubmed: 7976495
Qual Health Res. 2011 Dec;21(12):1692-704
pubmed: 21810994
Ann Fam Med. 2005 Jan-Feb;3(1):64-9
pubmed: 15671193
Arch Osteoporos. 2016;11:19
pubmed: 27129487
Arch Osteoporos. 2012;7:115-24
pubmed: 23225289
Semin Arthritis Rheum. 2006 Apr;35(5):293-305
pubmed: 16616152
Arch Osteoporos. 2011;6:59-155
pubmed: 22886101
J Geriatr Phys Ther. 2011 Apr-Jun;34(2):72-81
pubmed: 21937896
Patient Prefer Adherence. 2015 Jun 19;9:821-30
pubmed: 26150702
Geriatr Nurs. 2009 Mar-Apr;30(2 Suppl):4-10
pubmed: 19345857
J Bone Miner Res. 2018 Sep;33(9):1585-1594
pubmed: 29637658
Arch Osteoporos. 2013;8:136
pubmed: 24113837
Gerontologist. 2011 Aug;51(4):530-9
pubmed: 21310768
Scand J Caring Sci. 2013 Sep;27(3):516-24
pubmed: 22924528
Soc Sci Med. 2006 Jun;62(11):2720-31
pubmed: 16356616
PLoS One. 2016 Jun 29;11(6):e0158365
pubmed: 27355576

Auteurs

B Merle (B)

INSERM Research Unit 1033, Université Lyon 1, Lyon, France. blandine.merle@inserm.fr.

C Dupraz (C)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.

J Haesebaert (J)

Hospices Civils de Lyon, HESPER EA 7425, Université Lyon 1, Lyon, France.

L Barraud (L)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.

M Aussedat (M)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.

C Motteau (C)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.

V Simon (V)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.

A M Schott (AM)

Hospices Civils de Lyon, HESPER EA 7425, Université Lyon 1, Lyon, France.

M Flori (M)

Collège Universitaire Médecine Générale, Université Lyon 1, Lyon, France.
EA 4129-Parcours Santé Systémique, Université Lyon 1, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH